Sophia Malki: A Woman on the Rise Sophia Malki: A Woman on the Rise Sophia Malki: A Woman on the Rise
First Half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline First Half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline First Half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
Reducing Stress in Horses – With Music Reducing Stress in Horses – With Music Click here to read more on the release of the Boehringer Ingelheim specially composed music track, designed to keep horses safe and "sound".
Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer’s trials Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer’s trials Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer’s trials
Boehringer Ingelheim and Junior Achievement: A decade of inspiring futures Boehringer Ingelheim and Junior Achievement: A decade of inspiring futures Boehringer Ingelheim celebrates its decade-long partnership and volunteering milestone.
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas Currency-adjusted net sales rose by 9.7 percent to 13.5 billion USD.
Helping a Local Community in a Time of Need Helping a Local Community in a Time of Need Helping a Local Community in a Time of Need
Animal Health | COVID-19 | Boehringer Ingelheim US Animal Health | COVID-19 | Boehringer Ingelheim US Click here to read more on how the COVID-19 pandemic has impacted the daily lives of veterinarians, livestock producers and others.
Vetmedica Inc to Sell Vaccine Portfolio | Boehringer Ingelheim US Vetmedica Inc to Sell Vaccine Portfolio | Boehringer Ingelheim US Read more on Boehringer Ingelheim Vetmedica Inc. entering into an agreement to sell feline, canine and rabies vaccines to Elanco Animal Health in the USA.
Arising Vaccines to Help Zoo Elephants | Boehringer Ingelheim US Arising Vaccines to Help Zoo Elephants | Boehringer Ingelheim US Find out how Boehringer Ingelheim is developing vaccines to help North African zoo elephants suffering from deadly infections and illness.